Pharma Reviews: ISSAR Pharma announces Out - Licensing of its Peptide-Based NCEs

“We take pride in being India's first ever company to conduct phase-1 clinical trials, and launch the first ever indigenous peptide drug, Melgain in market ...
Read more: ISSAR Pharma announces Out - Licensing of its Peptide-Based NCEs